Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-22 Sale | 2026-06-24 7:29 pm | OnKure Therapeutics Inc. | OKUR | Saccomano Nicholas A President and CEO | 86 | $4.3963 | $378 | 11,247 (Direct) | View |
| 2026-06-22 Sale | 2026-06-24 7:27 pm | OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer | 303 | $4.3963 | $1,332 | 18,802 (Direct) | View |
| 2026-03-23 Sale | 2026-03-24 6:57 pm | OnKure Therapeutics Inc. | OKUR | Saccomano Nicholas A President and CEO | 86 | $4.1565 | $357 | 7,333 (Direct) | View |
| 2026-03-23 Sale | 2026-03-24 6:56 pm | OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer | 301 | $4.1565 | $1,251 | 16,000 (Direct) | View |
| 2025-12-22 Sale | 2025-12-23 8:09 pm | OnKure Therapeutics Inc. | OKUR | Saccomano Nicholas A President and CEO | 87 | $2.9677 | $258 | 7,419 (Direct) | View |
| 2025-12-22 Sale | 2025-12-23 8:08 pm | OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer | 302 | $2.9677 | $896 | 16,301 (Direct) | View |
| 2025-09-22 Sale | 2025-09-24 7:42 pm | OnKure Therapeutics Inc. | OKUR | Saccomano Nicholas A President and CEO | 88 | $2.6235 | $231 | 3,506 (Direct) | View |
| 2025-09-22 Sale | 2025-09-24 7:41 pm | OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer | 303 | $2.6235 | $795 | 12,603 (Direct) | View |
| 2025-06-23 Sale | 2025-06-25 6:52 pm | OnKure Therapeutics Inc. | OKUR | Saccomano Nicholas A President and CEO | 88 | $2.3842 | $210 | 3,594 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-07 Option Award | 2026-08-11 4:43 pm | N/A 2036-08-06 | OnKure Therapeutics Inc. | OKUR | Mathers Edward T Director | 22,350 | $0 | 22,350 (Direct) | View |
| 2026-08-07 Option Award | 2026-08-11 4:40 pm | N/A 2036-08-06 | OnKure Therapeutics Inc. | OKUR | Ratcliffe Liam Director | 22,350 | $0 | 22,350 (Direct) | View |
| 2026-08-07 Option Award | 2026-08-11 4:39 pm | N/A 2036-08-06 | OnKure Therapeutics Inc. | OKUR | Phillips Andrew John Director | 22,350 | $0 | 22,350 (Direct) | View |
| 2026-08-07 Option Award | 2026-08-11 4:39 pm | N/A 2036-08-06 | OnKure Therapeutics Inc. | OKUR | Manke Isaac Director | 315,300 | $0 | 315,300 (Direct) | View |
| 2026-08-07 Option Award | 2026-08-11 4:37 pm | N/A 2036-08-06 | OnKure Therapeutics Inc. | OKUR | Jansen Valerie Malyvanh Director | 22,350 | $0 | 22,350 (Direct) | View |
| 2026-08-07 Option Award | 2026-08-11 4:36 pm | N/A 2036-08-06 | OnKure Therapeutics Inc. | OKUR | GREY MICHAEL G Director | 22,350 | $0 | 22,350 (Direct) | View |
| 2026-08-07 Option Award | 2026-08-11 4:31 pm | N/A 2036-08-06 | OnKure Therapeutics Inc. | OKUR | Carruthers R Michael Director | 22,350 | $0 | 22,350 (Direct) | View |
| 2026-08-07 Option Award | 2026-08-11 4:27 pm | N/A 2036-08-06 | OnKure Therapeutics Inc. | OKUR | Saccomano Nicholas A President and CEO | 721,423 | $0 | 721,423 (Direct) | View |
| 2026-08-07 Option Award | 2026-08-11 4:26 pm | N/A 2036-08-06 | OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer | 191,714 | $0 | 191,714 (Direct) | View |
| 2026-08-07 Option Award | 2026-08-11 4:25 pm | N/A 2036-08-06 | OnKure Therapeutics Inc. | OKUR | Hartley Dylan Chief Scientific Officer | 187,603 | $0 | 187,603 (Direct) | View |
| 2026-08-07 Option Award | 2026-08-11 4:23 pm | N/A 2036-08-06 | OnKure Therapeutics Inc. | OKUR | Agresta Samuel Chief Medical Officer | 199,984 | $0 | 199,984 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 6:32 pm | N/A 2036-06-03 | OnKure Therapeutics Inc. | OKUR | Mathers Edward T Director | 7,650 | $0 | 7,650 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 6:27 pm | N/A 2036-06-03 | OnKure Therapeutics Inc. | OKUR | Ratcliffe Liam Director | 1,275 | $0 | 1,275 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 6:26 pm | N/A 2036-06-03 | OnKure Therapeutics Inc. | OKUR | Phillips Andrew John Director | 7,650 | $0 | 7,650 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 6:25 pm | N/A 2036-06-03 | OnKure Therapeutics Inc. | OKUR | Jansen Valerie Malyvanh Director | 7,650 | $0 | 7,650 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 6:24 pm | N/A 2036-06-03 | OnKure Therapeutics Inc. | OKUR | GREY MICHAEL G Director | 7,650 | $0 | 7,650 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-08 6:23 pm | N/A 2036-06-03 | OnKure Therapeutics Inc. | OKUR | Carruthers R Michael Director | 7,650 | $0 | 7,650 (Direct) | View |
Ownership | 2026-04-07 9:15 pm | N/A N/A | OnKure Therapeutics Inc. | OKUR | AI Biotechnology LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 0 | $0 | 9,638,554 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-03 3:29 pm | N/A 2036-03-31 | OnKure Therapeutics Inc. | OKUR | Saccomano Nicholas A President and CEO | 330,000 | $0 | 330,000 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-03 3:27 pm | N/A 2036-03-31 | OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-03 3:26 pm | N/A 2036-03-31 | OnKure Therapeutics Inc. | OKUR | Hartley Dylan Chief Scientific Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-03 3:25 pm | N/A 2036-03-31 | OnKure Therapeutics Inc. | OKUR | Agresta Samuel Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2026-03-31 Option Award | 2026-04-01 5:25 pm | N/A 2036-03-30 | OnKure Therapeutics Inc. | OKUR | Ratcliffe Liam Director | 15,300 | $0 | 15,300 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-02 4:16 pm | N/A N/A | OnKure Therapeutics Inc. | OKUR | Mathers Edward T Director | 3,911 | $0 | 15,310 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-02 4:10 pm | N/A N/A | OnKure Therapeutics Inc. | OKUR | Manke Isaac Director | 5,258 | $0 | 20,583 (Direct) | View |
| 2025-09-30 Option Award | 2025-10-02 4:29 pm | N/A N/A | OnKure Therapeutics Inc. | OKUR | Mathers Edward T Director | 4,125 | $0 | 11,399 (Direct) | View |
| 2025-09-30 Option Award | 2025-10-02 4:16 pm | N/A N/A | OnKure Therapeutics Inc. | OKUR | Manke Isaac Director | 5,545 | $0 | 15,325 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-02 4:33 pm | N/A N/A | OnKure Therapeutics Inc. | OKUR | Mathers Edward T Director | 4,694 | $0 | 7,274 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-02 4:26 pm | N/A N/A | OnKure Therapeutics Inc. | OKUR | Manke Isaac Director | 6,311 | $0 | 9,780 (Direct) | View |